Abstract. The analytical note describes the main types and features of marketing services in the pharmaceutical sector and analyses the system of regulatory requirements for the registration (authorisation) of pharmaceutical products and the provision of services for their promotion, as defined in the secondary legislation of the European Union (in particular, in the Community Code relating to medicinal products for human use). The legislation of France, Denmark, Portugal, the Netherlands and Poland has been reviewed with regard to the regulation of pharmaceutical marketing activities in the internal market of the European Union, and the features of legislative regulation of restrictions on financial relations through the introduction of transparency mechanisms and ethical standards have been analysed.

Keywords: European Union legislation, pharmaceutical marketing, marketing services, prescription medicines, over-the-counter medicines, registration (authorisation) of medicinal products.

Link_ua

12/2025